CIC
XBI icon

Carnegie Investment Counsel’s SPDR S&P Biotech ETF XBI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$4.11M Sell
49,615
-1,830
-4% -$152K 0.08% 183
2025
Q1
$3.76M Sell
51,445
-49,661
-49% -$3.62M 0.09% 175
2024
Q4
$9.11M Buy
101,106
+5,683
+6% +$512K 0.26% 103
2024
Q3
$9.43M Buy
95,423
+2,975
+3% +$294K 0.28% 97
2024
Q2
$8.57M Buy
92,448
+9,055
+11% +$839K 0.27% 99
2024
Q1
$7.91M Buy
83,393
+20,282
+32% +$1.92M 0.25% 103
2023
Q4
$5.64M Sell
63,111
-34,429
-35% -$3.07M 0.19% 125
2023
Q3
$7.12M Sell
97,540
-4,067
-4% -$297K 0.27% 98
2023
Q2
$8.45M Buy
101,607
+6,075
+6% +$505K 0.31% 93
2023
Q1
$7.28M Sell
95,532
-1,627
-2% -$124K 0.29% 98
2022
Q4
$8.06M Buy
97,159
+2,109
+2% +$175K 0.35% 81
2022
Q3
$7.54M Buy
95,050
+11,767
+14% +$933K 0.36% 81
2022
Q2
$6.19M Sell
83,283
-29,403
-26% -$2.18M 0.28% 99
2022
Q1
$10.1M Buy
112,686
+19,050
+20% +$1.71M 0.37% 81
2021
Q4
$10.5M Sell
93,636
-16,368
-15% -$1.83M 0.35% 88
2021
Q3
$13.8M Buy
110,004
+6,973
+7% +$877K 0.52% 64
2021
Q2
$14M Buy
103,031
+18,083
+21% +$2.45M 0.53% 62
2021
Q1
$11.5M Buy
84,948
+7,813
+10% +$1.06M 0.48% 67
2020
Q4
$10.9M Buy
77,135
+1,601
+2% +$225K 0.49% 66
2020
Q3
$8.42M Buy
75,534
+190
+0.3% +$21.2K 0.43% 71
2020
Q2
$8.43M Buy
75,344
+1,943
+3% +$217K 0.48% 61
2020
Q1
$5.68M Sell
73,401
-27,300
-27% -$2.11M 0.39% 76
2019
Q4
$9.58M Buy
100,701
+153
+0.2% +$14.6K 0.55% 54
2019
Q3
$7.67M Sell
100,548
-5,124
-5% -$391K 0.49% 63
2019
Q2
$9.27M Buy
105,672
+6,617
+7% +$580K 0.6% 47
2019
Q1
$8.97M Buy
99,055
+2,717
+3% +$246K 0.62% 48
2018
Q4
$6.91M Sell
96,338
-42,221
-30% -$3.03M 0.64% 42
2018
Q3
$11.1M Buy
138,559
+39,031
+39% +$3.12M 0.91% 31
2018
Q2
$9.44M Buy
99,528
+2,233
+2% +$212K 0.72% 42
2018
Q1
$8.92M Buy
97,295
+1,906
+2% +$175K 0.75% 41
2017
Q4
$8.72M Buy
95,389
+4,313
+5% +$394K 0.77% 36
2017
Q3
$7.69M Buy
91,076
+2,021
+2% +$171K 0.9% 29
2017
Q2
$6.87M Buy
89,055
+4,194
+5% +$324K 0.84% 33
2017
Q1
$5.87M Buy
84,861
+3,196
+4% +$221K 0.73% 44
2016
Q4
$5.1M Buy
81,665
+49,830
+157% +$3.11M 0.68% 50
2016
Q3
$1.88M Buy
31,835
+25,340
+390% +$1.5M 0.27% 104
2016
Q2
$400K Buy
+6,495
New +$400K 0.06% 240
2014
Q2
Sell
-2,753
Closed -$392K 233
2014
Q1
$392K Sell
2,753
-19,274
-88% -$2.74M 0.1% 158
2013
Q4
$2.87M Buy
22,027
+960
+5% +$125K 0.77% 49
2013
Q3
$2.72M Sell
21,067
-1,246
-6% -$161K 0.84% 39
2013
Q2
$2.33M Buy
+22,313
New +$2.33M 0.76% 47